The data displayed for this chart goes back to 1997, however we hope to be able to offer deeper historic information at a future point ...

The data displayed for this chart goes back to 1997, however we hope to be able to offer deeper historic information at a future point ...

As of 11:35:46 AM EST. Market Open.

announced today that the Central Drugs Standard Control Organisation (CDSCO) in India has approved Afrezza (insulin human) Inhalation Powder in adults. The CDSCO decision follows existing ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Let’s look at what the charts indicate for Adobe stock and how ... while the relative strength index (RSI) at 66.42 suggests Adobe stock is edging closer to overbought territory.

Drugmaker Cipla has got regulatory approval to market Afrezza, a rapid acting insulin delivered through an inhaler, as compared to other insulins given through injections. The Central Drugs ...

announced today that the Central Drugs Standard Control Organisation (CDSCO) in India has approved Afrezza (insulin human) Inhalation Powder in adults. The CDSCO decision follows existing approvals in ...

MannKind (MNKD) and Cipla announced that the Central Drugs Standard Control Organisation in India has approved Afrezza Inhalation Powder in adults. The CDSCO decision follows existing approvals in ...